To determine the relationships between the circadian blood pressure profile and left ventricular mass, hormonal pattern and insulin sensitivity indices in patients with active acromegaly, ambulatory 24-h blood pressure monitoring (ABPM) was recorded in 25 subjects (47.0 ؎ 15.1 years, range 23-72). Serum growth hormone (GH) and insulin-like growth factor-1, fasting and mean plasma glucose and insulin during oral glucose tolerance test (OGTT), insulinogenic index, the sum of the plasma insulin levels and the homeostasis model insulin resistance index (Homa's index) were determined. Left ventricular mass index (LVMI) was calculated from two-dimensional guided M-mode echocardiogram. The prevalence of hypertension was 56% (n ‫؍‬ 14) and 40% (n ‫؍‬ 10) according to sphygmomanometric measurements and ABPM, respectively. Non-dipping profile was observed in six of 10 hypertensives and in six of 15 normotensives. Serum growth hormone, fasting glucose, the area under the serum insulin curve and LVMI were higher for acromegalics with non-dipping profile than for dippers (all of them, P Ͻ 0.05). In nondippers daytime heart rate was higher than night time (P Ͻ 0.001). In conclusion, the main observations in the present study suggested that both normotensive and hypertensive acromegalics had a highly prevalent nondipping profile with a preserved circadian pattern of heart rate, that was associated with higher levels of serum GH. The disturbance in nocturnal blood fall in normotensives was associated with a decreased insulin sensitivity. The role of GH in blood pressure circadian rhythm regulation in essential hypertension deserves further studies. Journal of Human Hypertension (2001) 15, 601-605
Introduction
Hypertension is the most common cardiovascular manifestation of acromegaly, occurring in about 30% of patients, mostly women. 1, 2 However, there are discrepancies in the prevalence of hypertension in acromegaly, among different authors it varies from 13% to 60%. 2, 3 Hypertensive patients with acromegaly tend to be older and to suffer from the disease for a longer period of time than non-hypertensive acromegalic patients. Hypertension is usually mild, uncomplicated and readily responsive to drugs in acromegalic patients. Nearly all patients with acromegaly have cardiomegaly, particularly after the fifth decade. 4 Biventricular hypertrophy and impaired diastolic and systolic functions are distinct features of uncomplicated acromegaly and are a consequence of a specific acromegalic cardiomyopathy that may be aggravated by hypertension. 5, 6 There is no direct relationship between the degree of cardiomegaly and the level of circulating growth hormone (GH). 5, 6 With only two exceptions 7, 8 hypertension in acromegalyc patients was studied with sphygmomanometric methods and hence, there is scanty information on the circadian variations in blood pressure (BP) and heart rate (HR). Moreover, the available results are contradictory. This issue may be of clinical relevance since recent studies suggest that these patients appear to have an increase in target organ damage. [9] [10] [11] The present study was designed to determine the 24-h ambulatory blood pressure (ABPM) profile in patients with active acromegaly, and to establish the relationship between ambulatory circadian BP, echocardiographically determined left ventricular mass, serum GH and insulin-like growth factor I (IGF-I), fasting and mean serum insulin values during 2 h oral glucose tolerance test (OGTT).
Patients and methods
Twenty-five patients with active acromegaly were included in the study (16 women and nine men, aged 47.0 Ϯ 15.1 years, range 23-72). Acromegaly was diagnosed on the basis of characteristic clinical features and confirmed by high serum GH concentrations, not suppressible below 2 ng/mL during a 75-g OGTT, associated with elevated serum IGF-I levels above the upper normal range and by demonstration of a pituitary tumor on magnetic resonance imaging in all cases. GH was measured by immunoradiometric assay (Serono Diagnostic, Milan, Italy) and IGF-I by radioimmunological assay (Nichols Institute Diagnostics, San Juan de Capistrano, USA). At least four blood samples were drawn over 24 h for GH measurements and the mean was used for statistical analysis, whilst IGF-I was determined on a single fasting sample. Intra-and interassay coefficients of variation were less than 2.35% and 2.67% for GH and 3.4% and 8.2% for IGF-I, respectively. Sensitivity for detection of GH and IGF-I were 0.02 ng/mL and 0.80 ng/mL, respectively. Three patients were recently diagnosed and 22 had persistent GH hypersecretion after trans-sphenoidal surgery and/or radiotherapy. None of the 22 unsuccessfully treated patients were on replacement endocrine therapies.
The diagnosis of hypertension was based on the mean of three or more measurements taken on two separate clinic visits (between 1 and 2 weeks apart) exceeding 140/90 mm Hg after being off all antihypertensive medication for 4 weeks. Other causes of secondary hypertension were excluded. None had been receiving any medical treatment for acromegaly for at least 3 months before the study.
Written informed consent was required from each patient, and the study was approved by the Ethics Committee of Buenos Aires School of Medicine. Body mass index (BMI) was calculated according to the formula body weight (kg)/height (m) 2 . Waist and hip circumferences were measured by one observer by means of a steel tape. OGTT was performed according to the recommendations of the National Diabetes Data Group. 12 During the week preceding this test, an isoenergetic diet containing 200 mg NaCl/day was prescribed. No eating or smoking was allowed after 8.00 pm on the day preceding the test. They were told not to engage in any significant physical activity before testing. The OGTT was started between 7.30 and 8.30 am. Plasma glucose and insulin concentrations in venous blood samples drawn from an indwelling antecubital venous catheter or needle were measured before and 15, 30, 60 and 120 min after glucose ingestion. Plasma glucose level was measured by means of the glucose oxidase method. Immunoreactive insulin was assayed in serum using a radioimmunoassay kit (Linco Lab Inc, Miami, FL, USA). 13 The lowest limit of detection of the assay was 15 pmol/L with an intra-assay coefficient of variation equal to 11.5% and interassay variation of 12%. This assay did not have a crossreaction with human proinsulin. The areas under the blood glucose curve (AUC glucose ), serum insulin curve (AUC insulin ) and insulin/glucose ratio (AUC insulin/glucose ratio ) were calculated using the trapezoidal integration. The mean insulin value was employed for estimation of insulin response to the OGTT, and is equal to 2 h insulin area (estimated by trapezoid rule) divided by 120 min. 14 Fasting serum insulin and mean values of serum insulin were transformed into log 10 respectively, so as to normalise their distribution in these analysis. The mean plasma fasting glucose and insulin, insulinogenic index (ratio of the increment of the insulin level to that of glucose level between 0 and 30 min after the OGTT) and ⌺IRI (the sum of the plasma insulin levels 0, 30, 60 and 120 min after the OGTT) of both groups were compared. In addition, the homeostasis model insulin resistance index (Homa's index) 15 a candidate for the simple assessment of insulin sensitivity, 16, 17 was calculated using the formula: fasting plasma glucose (mg/dl) × fasting insulinaemia (U/ml) Ϭ 405, and the mean indices of the groups were compared.
Within 48 h of OGTT, always on a working day, under the recommendations of continuing their diets and habitual activities, 24-h ABPM was performed. All subjects were instructed to rest or sleep between 11.00 pm and 7.00 am. A portable Takeda TM 2421 (A&D) BP and HR device provided with an appropriate cuff was adapted to left patient arm and was programmed to record BP and HR at 15-min intervals during the 7.00 am to 11.00 pm daytime period and at 30-min intervals during the 11.00 pm to 7.00 am night-time period. The BP data from the monitor were reviewed before recording to ensure they read within Ϯ3 mm Hg of simultaneously measured sphygmomanometer values and to secure they were within the range of the subject's office BP values. Subjects who stated that they had not rested between 11.00 pm to 7.00 am were not included in the study. The patients who exhibited falls (Ͼ10%) in systolic BP (SBP) and diastolic BP (DBP) corresponding to the 95th percentile of a normotensive population during the time period 11.00 pm to 7.00 am with respect to the values for 7.00 am to 11.00 pm were classified as dippers, all those not exhibiting this characteristic being considered nondippers. Twenty-four hour mean SBP-heart rate (pressure-rate) product for every patient was calculated from the ambulatory data as SBP × heart rate/100 (units). By ABPM, hypertension was defined as mean BP values exceeding 136/84 mm Hg for 24-h BP values. 18 Two-dimensional guided M-mode echocardiography with a 3 Mhz phased array ultrasound transducer and an ATL unit was performed in all patients by a single investigator. Left ventricular mass (LVM) was calculated with the formula validated by Devereux et al. 19 Left ventricular mass index (LVMI) was obtained by dividing LVM by body surface area. Patients were considered to have left ventricular hypertrophy with LVMI у135 g/m 2 in men and у110 g/m 2 in women.
Statistical analysis
All data are expressed as mean Ϯ s.d. Comparisons between the groups were performed by one-way analysis of variance (ANOVA) and the Fisher exact test. When variances were similar, one-tailed Student's t-test for independent samples was applied. If differences were found, the non-parametric Mann-Whitney test was used for comparisons between two groups. All statistical analyses were performed using SPSS Base 7.5 Statistical Software (SPSS Inc, Chicago, IL, USA). In all cases P Ͻ 0.05 was taken to be statistically significant.
Results

Subjects characteristics
Clinical characteristics and the office BP data of the normotensive and hypertensive acromegalic patients are presented in Table 1 . Age was higher in hypertensive acromegalics than in normotensive acromegalics (P Ͻ 0.01). AUC glucose was higher in hypertensives than in normotensives whereas insulinogenic index was higher in normotensives than in hypertensive acromegalics (2.38 Ϯ 1.71 vs 1.24 Ϯ 0.81, P Ͻ 0.05). There were no differences in GH, IGF-I, fasting insulin, AUC insulin , AUC insulin:glucose , ⌺IRI, sum of the plasma insulin levels at 0, 30, 60 and 120 min after the OGTT; *P Ͻ 0.05, **P Ͻ 0.01.
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Homa's index nor ⌺IRI. Both groups had similar BMI, waist:hip ratio and hypertensives had greater LVMI than normotensives.
Blood pressures
The observed prevalence of hypertension was 56% (n ϭ 14) and 40% (n ϭ 10) according to sphygmomanometric measurements and ABPM, respectively. Ten patients (40%) were found to be normotensive by both clinical and ABPM methods. Hypertension increased with age: according to clinical measurements it was more frequent in patients aged Ͼ40 years (11 out of 14 patients) than in patients aged р40 years (three out of 10 patients), P Ͻ 0.05. A similar but nonsignificant tendency was confirmed by ABPM: hypertension was diagnosed in eight out of 15 patients aged Ͼ40 years and in two out of 10 patients aged у40 years. Non-dipping profile was observed at ABPM in six out of 10 (60%) hypertensives and in six out of 15 (40%) normotensives. Serum GH, fasting glucose, AUC insulin , 24-h HR, 24-h mean SBP-heart rate product, and LVMI were higher for acromegalics with non-dipping profile than for dippers ( Table 2 and 
Discussion
The present study provides the first detailed evaluation of the relationships between the circadian blood pressure profile and left ventricular mass and hormonal pattern in patients with active acromegaly. The main observation in the present study was that both normotensive and hypertensive acromegalics showed a highly prevalent non-dipping profile. Many disease states are characterised by nocturnal BP dysregulation. While certain secondary causes of hypertension have blunted or absent nocturnal declines in BP, 20,21 many patients with the non-dipping circadian pattern of BP have essential hypertension. In secondary hypertension, there may even be an increase in nocturnal BP such that daytime values are exceeded and the phasing of the circadian rhythm is reversed. Derangements in autonomic nervous system activity, sleep disordered breathing (such as sleep apnea), and alterations in sleep architecture and duration are well recognised causes of change in the circadian BP profile. 22 Little is actually known about the pathophysiology leading to a reduced nocturnal fall in BP in hypertensives and mostly in normotensives, but advanced age and African-American ethnicity may be demographic markers for non-dippers. 23 In addition, there are data to suggest that hypertensive patients who are salt sensitive are more likely to be non-dippers than patients who are salt resistant. 24 Our results are in contrast with those observed by Minniti et al, 7 who in only one out of seven acromegalics with hypertension observed the absence of the physiological night-time decrease of BP, but they are in agreement with those observed by Terzolo et al, 8 who in five out of seven defined as hypertensives by ABPM found a non-dipper, altered night-day ratio for BP. In essential hypertensives it was observed that the ratio of fasting insulin to glucose was higher in non-dippers. 25 It has been shown in previous studies that the insulinogenic index, which may reflect the early response of insulin secretion to glucose loading, declined as the glucose tolerance changed from normal to a diabetic pattern. 16, 17 In normotensive acromegalic patients we observed a marginally significant higher insulinogenic index than in hypertensive acromegalics. This suggests that in hypertensive acromegalics glucose tolerance deteriorates from a normal to a diabetic pattern. 16 It appears as a signal of first step of deterioration of insulin sensitivity in hypertensives because other indices of insulin resistance as fasting insulin, AUC insulin , AUC insulin:glucose , Homa's index and ⌺IRI were not different in both groups. However, the differences in glucose tolerance and LVMI observed between hypertensive and normotensive acromegalics probably depend on both hypertension and aging, because the older age of the hypertensives. Our results support the view that normotensive and hypertensive non-dippers showed higher insulin resistance than dippers as it is reflected by a higher level of AUC insulin . In this study both office BP and ABPM in dippers and non-dippers were similar with the exception of night time SBP and they have similar age, suggesting that not only non-dipping behaviour but also the higher levels of serum GH observed in non-dippers are at least in part responsible for the greater LVMI. Besides, in our study both normotensive and hypertensive acromegalics with non-dipper profile showed higher levels of 24-h HR, 24-h mean SBP-HR product, than those for dippers. Furthermore, the higher prevalence of increased LVMI observed in non-dippers than in dipper patients in this study is associated with high risk of cardiovascular complications. 11, 26 This may be, at least in some patients, attributed to the acromegalic cardiomyopathy which is related to higher collagen content than normal myocardium. 27 The pathogenesis of hypertension in acromegaly is uncertain. A number of studies have suggested that GH itself inducing structural changes, probably through their effects on collagen deposition and smooth muscle cell growth 28 and hypervolemia 29 may be responsible for hypertension. Furthermore, surgery, pituitary irradiation, and/or medical therapy significantly reduces BP in hypertensive acromegalic patients. 30 It has been suggested that the sympathetic nervous system or other factors controlling renal sodium handling (atrial natriuretic factor, digitalis-like factors) 15 may be involved.
In the present study HR exhibited a preserved circadian pattern even in non-dipper acromegalics suggesting that at least sympathetic activity diminished while asleep. It has been pointed out that the disturbances in nocturnal BP fall and a dissociation between circadian profile of BP and HR as seen in our patient series are observed more frequently in secondary types of hypertension. The presence of a non-dipping profile in six out of 15 normotensive acromegalics in our study suggests a direct effect of GH and IGF-I on BP regulation. These results suggest that non-dipping profile is an important feature of active acromegaly, and is associated with insulin resistance even in those of the normotensive group.
Our findings that normotensive and hypertensive acromegalics with a non-dipping profile have higher levels of serum GH should serve to motivate further investigation on the role of this hormone in the circadian BP profile.
